REVERSIBLE STEROID-INDUCED HYPERTROPHIC CARDIOMYOPATHY WITH LEFT-VENTRICULAR OUTFLOW TRACT OBSTRUCTION IN 2 NEWBORNS

被引：9

作者：

HANEY, I ^{[1
]}

LACHANCE, C ^{[1
]}

VANDOESBURG, NH ^{[1
]}

FOURON, JC ^{[1
]}

机构：

[1] HOP ST JUSTINE,DIV CARDIOL,PEDIAT CARDIOL UNIT,MONTREAL,PQ H3T 1C5,CANADA

来源：

AMERICAN JOURNAL OF PERINATOLOGY | 1995年 / 12卷 / 04期

关键词：

HYPERTROPHIC CARDIOMYOPATHY; STEROID THERAPY; BRONCHOPULMONARY DYSPLASIA;

D O I：

10.1055/s-2007-994472

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Dexamethasone is now frequently used in the treatment of bronchopulmonary dysplasia. We report on two premature babies receiving dexamethasone who developed symptomatic myocardial hypertrophy and left ventricular outflow tract obstruction, as documented by M-mode echocardiography and Doppler studies. A normal heart was recorded on echocardiography before and after dexamethasone treatment. The patients had no known risk factors associated with the development of obstructive hypertrophic cardiomyopathy.

引用

页码：271 / 274

页数：4

共 13 条

[1]

Werner J.C., Sicard R.E., Hansen T.W.R., Et al., Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia, J Pediatr, 120, pp. 286-291, (1992)

[2]

Cummings J.J., D'Eugenio D.B., Gross S.J., A Controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia, N Engl J Med, 320, pp. 1505-1510, (1989)

[3]

Harkavy K.L., Scanlon J.W., Chowdhry P.K., Grylack L.J., Dexamethasone therapy for chronic king disease in ventilator and oxygen-dependent infants: a controlled trial, J Pediatr, 115, pp. 979-983, (1989)

[4]

Alkalay A.L., Pomerance J.J., Puri A.R., Et al., Hypothalamic pituitary-adrenal axis function in very low birth weight infants treated with dexamethasone, Pediatrics, 86, pp. 204-210, (1990)

[5]

Collaborative Dexamethasone Trial Group Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial, Pediatrics, 88, pp. 421-427, (1991)

[6]

Kazzi N.J., Brans Y.W., Poland R.L., Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation, Pediatrics, 86, pp. 722-727, (1990)

[7]

Israel B.A., Sherman F.S., Guthrie R.D., Cardiac hypertrophy associated with the use of dexamethasone in premature infants, Pediatr Res, 29, (1991)

[8]

Schuster, Gidding S.S., Possible relationship of acquired hypertrophic cardiomyopathy to corticosteroid therapy in premature infants with bronchopulmonary dysplasia, Pediatr Res, 27, (1990)

[9]

Sicard R.F., Werner J.C., Dexamethasone induced cardiomegaly in neonatal rats, Pediatr Res, 29, (1991)

[10]

Czerwinski S.M., Kurowski T.T., McKee E.E., Et al., Myosin heavy chain turnover during cardiac mass changes by glucocorticoids, J Appl Physiol, 70, pp. 300-305, (1991)

← 1 2 →